Experts Driving MedTech Growth

Akiva Podolsky is co-founder of Geneva Private Equity. Akiva is dynamic strategist and financial engineer, leading the alternative investments arm of Geneva. Akiva also manages the ultra-high-net-worth client relations and family office outreach for Geneva.

As a former senior asset manager for a prestigious family office, Akiva successfully oversaw a portfolio of over 3,000 apartment units under his direct purview, demonstrating his expertise in large-scale property operations, strategic asset optimization, and institutional-level real estate management. His comprehensive background in property management provided him with deep operational insights and hands-on experience across all facets of real estate investment, finance and management.

Philip Kahn is CFO at Geneva Private Equity, with more than a decade of experience in healthcare technology, finance, and strategic advisory. He has served as CFO of multiple entities, overseeing financial strategy, reporting, and transactions across international, multi-entity organizations. Philip previously led financial operations at value-based care EHR provider Integra Connect, where he drove improvements in forecasting, revenue recognition, and ERP optimization.

He began his career as an auditor with PwC, supporting audits for leading healthcare and life sciences companies. Throughout his career, Philip has worked with organizations including Eli Lilly, Johnson & Johnson, Pfizer, AbbVie, Moderna, Roche, AstraZeneca, Johns Hopkins, and Children’s National Medical Center. A CPA licensed in Ohio and Maryland, he is recognized for building scalable finance teams and delivering the financial clarity needed to support growth in complex, regulated sectors.

Warren Wright is the Technology Director at Geneva Private Equity, with 35 years of experience in business development, finance, and technology. As former CEO of SEAD Software LLC, he led the development of a cutting-edge data analytics platform for enterprises. Warren’s prior roles include CEO of Direct Insite Corp., serving global clients like IBM, EDS, and Siemens, and a technology Consultant for firms including MTMC, Clarity Diagnostics, and Clarity Lab Solutions amongst many others. His strategic planning and technology expertise help to guide Geneva’s MedTech investments, driving innovation and growth.

Dr. Joseph M. Chalil, MD, MBA, FACHE, serves as Chief Medical Advisor at Geneva Private Equity, leveraging over two decades of expertise in healthcare strategy, life sciences, and biotechnology investments. He has held leadership roles at Abbott, Hoffman-La Roche, Boehringer Ingelheim, and DBV Technologies. A U.S. Navy Medical Corps veteran, Dr. Chalil is the U.S. Country Manager at ICHORtec GmbH, Managing Partner at Parker Lloyd, best-selling author of Beyond the COVID-19 Pandemic and India Beyond the Pandemic, and Adjunct Professor at Nova Southeastern University.

Avi Grossman is the Director of Investor Relations and Strategic Marketing at Geneva Private Equity. He brings experience across capital markets, compliance, and early-stage technology, supported by involvement in more than $200M of multifamily transactions and multiple equity raises. His background includes managing accredited investor onboarding and regulatory documentation, as well as working with early-stage companies on product development, market positioning, and go-to-market execution. Avi holds an MBA from Baruch College with PMP, PSM, and PMA Core certifications.

Senior Director, Portfolio Companies - Growth-focused leader, excelling in entrepreneurship, business strategy, and sales, launching successful entrepreneurial ventures.

Dr. Barry D. Mangel, M.D. serves as Chief, Clinical Service Lines at Wellstar Health System, a leading integrated healthcare network in Georgia. In this role, he is responsible for enterprise-wide clinical service-line strategy, operational alignment, and quality performance across multiple specialties. His appointment reflects expanded leadership following years of guiding cardiovascular services at the system level.

Dr. Mangel is a board-certified interventional cardiologist with more than 30 years of clinical experience. He earned his medical degree through Boston University’s combined B.A./M.D. program and completed residency training at Thomas Jefferson University Hospital, followed by a cardiovascular fellowship at Beth Israel Deaconess Medical Center / Harvard Medical School. Widely recognized for clinical excellence, he has been named among “Top Doctors” by Castle Connolly and Atlanta Magazine on multiple occasions. Dr. Mangel brings a combination of deep clinical insight and operational leadership.

Raphael L. Yechieli, MD, is an Associate Professor of Radiation Oncology at the University of Miami Miller School of Medicine and Sylvester Comprehensive Cancer Center. He also serves as Medical Director and Service Chief of Radiation Oncology at Jackson Memorial Hospital, with appointments at the University of Miami Hospital and Sylvester Comprehensive Cancer Center.His clinical practice focuses on advanced, noninvasive radiation therapies for complex malignancies, with expertise in sarcoma, lung, and brain tumors, as well as select benign conditions requiring highly targeted treatment.

Dr. Yechieli is board-certified by the American Board of Radiology and brings over a decade of academic, clinical, and leadership experience. He earned his medical degree from the University of Maryland School of Medicine and completed residency training in Radiation Oncology at Henry Ford Hospital. A nationally recognized clinician and published investigator, he has contributed extensively to the peer-reviewed literature and held leadership roles within the American Society for Radiation Oncology and academic medical institutions. He brings a deep clinical, operational, and academic perspective to Geneva Private Equity’s Medical Advisory Board.